Deutsche Bank
RPRX

Deutsche Bank’s Repros Therapeutics Inc. RPRX Stock Holding History

Deutsche Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-993
Closed -$9K – 6615
2014
Q4 		$9K Sell
993
-7
-0.7% -$60 ﹤0.01% 5762
2014
Q3 		$9K Hold
1,000
– – ﹤0.01% 5438
2014
Q2 		$17K Hold
1,000
– – ﹤0.01% 5373
2014
Q1 		$7K Hold
1,000
– – ﹤0.01% 5130
2013
Q4 		$5K Buy
+1,000
New +$18.9K ﹤0.01% 5048

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Deutsche Bank's RPRX Position: Q4 2016 in Review

Deutsche Bank sold out of Repros Therapeutics Inc. (RPRX) in Q4 2016, closing a stake of 2,446 shares — an estimated $5K sold.

Deutsche Bank first reported a position in RPRX in Q2 2013 and held it in 14 quarters. The position peaked at $1.74M in Q2 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

  • Deutsche Bank reported no remaining Repros Therapeutics Inc. position as of Q4 2016 after selling out during the quarter.
  • Deutsche Bank sold 2,446 Repros Therapeutics Inc. shares in Q4 2016, an estimated $5K.
  • Deutsche Bank first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 14 quarters.
  • Deutsche Bank's Repros Therapeutics Inc. position peaked at $1.74M in Q2 2013.
  • 43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.